Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms

LJ Stevens, AJ Pruijssers, HW Lee… - Science translational …, 2022 - science.org
The nucleoside analog remdesivir (RDV) is a Food and Drug Administration–approved
antiviral for treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
被引用次数：135 相关文章
[HTML] nih.gov

[HTML][HTML] Mutations in the SARS-CoV-2 RNA dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms

LJ Stevens, AJ Pruijssers, HW Lee, CJ Gordon… - Science Translational … - ncbi.nlm.nih.gov
The nucleoside analog remdesivir (RDV) is a Food and Drug Administration (FDA)-
approved antiviral for treatment of severe acute respiratory syndrome coronavirus 2 (SARS …

Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms.

LJ Stevens, AJ Pruijssers, HW Lee… - Science …, 2022 - search.ebscohost.com
The nucleoside analog remdesivir (RDV) is a Food and Drug Administration–approved
antiviral for treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms.

LJ Stevens, AJ Pruijssers, HW Lee… - Science Translational …, 2022 - europepmc.org
The nucleoside analog remdesivir (RDV) is a Food and Drug Administration (FDA)-
approved antiviral for treatment of severe acute respiratory syndrome coronavirus 2 (SARS …
[PDF] scienceopen.com

[PDF][PDF] Mutations in the SARS-CoV-2 RNA dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms

LJ Stevens, AJ Pruijssers, HW Lee, CJ Gordon… - scienceopen.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have caused
more than 850,000 deaths in the United States and over 5 million deaths worldwide (1, 2) …

Mutations in the SARS-CoV-2 RNA dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms

LJ Stevens, AJ Pruijssers, HW Lee… - Science Translational …, 2022 - cdr.lib.unc.edu
The nucleoside analog remdesivir (RDV) is a Food and Drug Administration (FDA)-
approved antiviral for treatment of severe acute respiratory syndrome coronavirus 2 (SARS …

Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms

LJ Stevens, AJ Pruijssers, HW Lee… - Science …, 2022 - pubmed.ncbi.nlm.nih.gov
The nucleoside analog remdesivir (RDV) is a Food and Drug Administration-approved
antiviral for treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
[PDF] archive.org

[PDF][PDF] Mutations in the SARS-CoV-2 RNA dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms

LJ Stevens, AJ Pruijssers, HW Lee, CJ Gordon… - scholar.archive.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have caused
more than 850,000 deaths in the United States and over 5 million deaths worldwide (1, 2) …

Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms.

LJ Stevens, AJ Pruijssers, HW Lee… - Science Translational …, 2022 - europepmc.org
The nucleoside analog remdesivir (RDV) is a Food and Drug Administration (FDA)-
approved antiviral for treatment of severe acute respiratory syndrome coronavirus 2 (SARS …